Optical Coherence Tomography Is Associated With Cognitive Impairment in Multiple Sclerosis

por Dreyer-Alster, Sapir, Gal, Aviva, Achiron, Anat
Publicado 2022

Prefrontal hemodynamics during forward and backward walking, with and without a cognitive task, in people with multiple sclerosis

por KUPCHENKO, Yana, DREYER-ALSTER, Sapir, BROSCHEID, Kim-Charline, KALRON, Alon
Publicado 2023

Humoral SARS-COV-2 IgG decay within 6 months in COVID-19 healthy vaccinees: The need for a booster vaccine dose?

por Achiron, Anat, Mandel, Mathilda, Dreyer-Alster, Sapir, Harari, Gil, Gurevich, Michael
Publicado 2021

No evidence for an association between alcohol consumption and Multiple Sclerosis risk: a UK Biobank study

por Dreyer-Alster, Sapir, Achiron, Anat, Giovannoni, Gavin, Jacobs, Benjamin M., Dobson, Ruth
Publicado 2022

SARS-CoV-2 antibody dynamics and B-cell memory response over time in COVID-19 convalescent subjects

por Achiron, Anat, Gurevich, Michael, Falb, Rina, Dreyer-Alster, Sapir, Sonis, Polina, Mandel, Mathilda
Publicado 2021

Longitudinal relationships between disability and gait characteristics in people with MS

por Dreyer-Alster, Sapir, Menascu, Shay, Dolev, Mark, Givon, Uri, Magalashvili, David, Achiron, Anat, Kalron, Alon
Publicado 2022

Motoric cognitive risk syndrome in people with multiple sclerosis: prevalence and correlations with disease-related factors

por Dreyer-Alster, Sapir, Menascu, Shay, Aloni, Roy, Givon, Uri, Dolev, Mark, Achiron, Anat, Kalron, Alon
Publicado 2022

Intravenous immunoglobulin treatment during pregnancy and the post-partum period in women with multiple sclerosis: A prospective analysis

por Menascu, Shay, Siegel-Kirshenbaum, Michal, Dreyer-Alster, Sapir, Warszawer, Yehuda, Magalashvili, David, Dolev, Mark, Mandel, Mathilda, Harari, Gil, Achiron, Anat
Publicado 2023

Targeted cognitive game training enhances cognitive performance in multiple sclerosis patients treated with interferon beta 1-a

por Menascu, Shay, Aloni, Roy, Dolev, Mark, Magalashvili, David, Gutman, Keren, Dreyer-Alster, Sapir, Tarpin-Bernard, Franck, Achiron, Ran, Harari, Gil, Achiron, Anat
Publicado 2021

Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies

por Achiron, Anat, Mandel, Mathilda, Dreyer-Alster, Sapir, Harari, Gil, Magalashvili, David, Sonis, Polina, Dolev, Mark, Menascu, Shay, Flechter, Shlomo, Falb, Rina, Gurevich, Michael
Publicado 2021

Author response to: Correspondence to humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies

por Achiron, Anat, Mandel, Mathilda, Dreyer-Alster, Sapir, Harari, Gil, Magalashvili, David, Sonis, Polina, Dolev, Mark, Menascu, Shay, Flechter, Shlomo, Falb, Rina, Gurevich, Michael
Publicado 2021

Immune response to the third COVID-19 vaccine dose is related to lymphocyte count in multiple sclerosis patients treated with fingolimod

por Achiron, Anat, Mandel, Mathilda, Gurevich, Michael, Dreyer-Alster, Sapir, Magalashvili, David, Sonis, Polina, Dolev, Mark, Menascu, Shay, Harari, Gil, Flechter, Shlomo, Falb, Rina
Publicado 2022

In-depth characterization of long-term humoral and cellular immune responses to COVID-19m-RNA vaccination in multiple sclerosis patients treated with teriflunomide or alemtuzumab

por Achiron, Anat, Mandel, Mathilda, Dreyer-Alster, Sapir, Magalashvili, David, Menascu, Shay, Warszawer, Yehuda, Dolev, Mark, Didikin, Maria, Harari, Gil, Sonis, Polina, Falb, Rina, Gurevich, Michael
Publicado 2023

Humoral immune response in multiple sclerosis patients following PfizerBNT162b2 COVID19 vaccination: Up to 6 months cross-sectional study

por Achiron, Anat, Mandel, Mathilda, Dreyer-Alster, Sapir, Harari, Gil, Dolev, Mark, Menascu, Shay, Magalashvili, David, Flechter, Shlomo, Givon, Uri, Guber, Diana, Sonis, Polina, Zilkha-Falb, Rina, Gurevich, Michael
Publicado 2021

COVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021

por Achiron, Anat, Dolev, Mark, Menascu, Shay, Zohar, Daniela-Noa, Dreyer-Alster, Sapir, Miron, Shmuel, Shirbint, Emanuel, Magalashvili, David, Flechter, Shlomo, Givon, Uri, Guber, Diana, Stern, Yael, Polliack, Michael, Falb, Rina, Gurevich, Michael
Publicado 2021

COVID-19 vaccination in patients with multiple sclerosis: Safety and humoral efficacy of the third booster dose

por Dreyer-Alster, Sapir, Menascu, Shay, Mandel, Mathilda, Shirbint, Emanuel, Magalashvili, David, Dolev, Mark, Flechter, Shlomo, Givon, Uri, Guber, Diana, Stern, Yael, Miron, Shmuel, Polliack, Michael, Falb, Rina, Sonis, Polina, Gurevich, Michael, Achiron, Anat
Publicado 2022